PERKINS CAPITAL MANAGEMENT INC
Sector Allocation
- Healthcare56.1%$74.6M
- Technology36.7%$48.8M
- Communication Services2.2%$2.9M
- Financials2.1%$2.8M
- Materials0.9%$1.2M
- Consumer Staples0.8%$1.1M
- Industrials0.6%$845,861
- Energy0.6%$803,031
AUM History
13fpro.ai/research/fund/perkins-capital-management-inc-884300
Conviction and streaks
Concentrating · top 10 = 52.2%From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.
Largest positions — Q2 2026
NTRA
$11.0MLLY
$10.4MAMD
$8.1MBFLY
$7.3MAXGN
$6.8MINUV
$6.5MQUIK
$5.1MIDXX
$5.1MBLZE
$4.9MMSFT
$4.2MVCYT
$3.5MOOMA
$3.4MPSNL
$3.2MCYRX
$3.1MCIEN
$3.1MLMAT
$2.4MMGNI
$1.9MABT
$1.8MUSIO
$1.7MONDS
$1.7M
Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.
13fpro.ai/research/fund/perkins-capital-management-inc-884300
PERKINS CAPITAL MANAGEMENT INC 13F holdings — Q2 2026
$133.0M portfolio (+24.6% QoQ) · 79 holdings · Q2 2026 13F · top 10 are 52% of the stock portfolio
$11.0M
8.3% of stocks
-8%This quarter+54.5%Since filed3+ qtrsHeld$10.4M
7.8% of stocks
-2%This quarter+7.0%Since filed3+ qtrsHeld$8.1M
6.1% of stocks
-10%This quarter+1.8%Since filed3+ qtrsHeld$7.3M
5.5% of stocks
-7%This quarter+1.2%Since filed3+ qtrsHeld$6.8M
5.1% of stocks
-12%This quarter-3.7%Since filed3+ qtrsHeldAIQuality40.7#2,077Est. buyEstimated buy price is Pro: unlock with a free trialTrimmed 2 qtrs in a row$6.5M
4.9% of stocks
-12%This quarter-56.5%Since filed3+ qtrsHeld$5.1M
3.9% of stocks
-16%This quarter-30.9%Since filed3+ qtrsHeld$5.1M
3.8% of stocks
No changeThis quarter+4.8%Since filed3+ qtrsHeld$4.9M
3.7% of stocks
-9%This quarter-26.0%Since filed3+ qtrsHeld$4.2M
3.1% of stocks
-2%This quarter+39.5%Since filed3+ qtrsHeldAIQualityAI quality score is Pro: unlock with a free trialEst. buyEstimated buy price is Pro: unlock with a free trialTrimmed 2 qtrs in a row
All holdings — PERKINS CAPITAL MANAGEMENT INC (Q2 2026)
79 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.
| # | Company | Held | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11 | VERACYTE, INC. | Healthcare | $3.5M | 2.6% | 60K | -20% | 3+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 12 | OOMA INC | Technology | $3.4M | 2.6% | 177K | -2% | 3+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 13 | Personalis, Inc. | Healthcare | $3.2M | 2.4% | 239K | — | 3+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 14 | Cryoport, Inc. | Healthcare | $3.1M | 2.4% | 200K | -2% | 3+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 15 | CIENA CORP | Technology | $3.1M | 2.3% | 6,300 | — | 3+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 16 | LEMAITRE VASCULAR INC | Healthcare | $2.4M | 1.8% | 25K | -2% | 3+ qtrsTrimmed 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 17 | MAGNITE, INC. | Technology | $1.9M | 1.4% | 99K | -17% | 3+ qtrsTrimmed 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 18 | ABBOTT LABORATORIES | Healthcare | $1.8M | 1.4% | 20K | -2% | 3+ qtrsTrimmed 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 19 | Usio, Inc. | Financials | $1.7M | 1.3% | 700K | -0.2% | 3+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 20 | Ondas Inc. | Technology | $1.7M | 1.3% | 201K | -0.2% | 3+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 21 | NEOGENOMICS INC | Technology | $1.6M | 1.2% | 110K | -17% | 3+ qtrsTrimmed 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 22 | Perion Network Ltd. | Technology | $1.6M | 1.2% | 165K | +5% | 3+ qtrsAdded 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 23 | NEOGEN CORP | Healthcare | $1.6M | 1.2% | 178K | -0.3% | 3+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 24 | Crexendo, Inc. | Communication Services | $1.6M | 1.2% | 213K | +9% | 3+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 25 | Alphatec Holdings, Inc. | Healthcare | $1.5M | 1.1% | 175K | +2% | 3+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 26 | $ABBV | AbbVie Inc. | Healthcare | $1.3M | 1.0% | 5,307 | -0.7% | |||
| 27 | $CREX | CREATIVE REALITIES, INC. | Technology | $1.2M | 0.9% | 300K | New | |||
| 28 | $LUCD | Lucid Diagnostics Inc. | Healthcare | $1.2M | 0.9% | 1.13M | -0.1% | |||
| 29 | $CDXS | CODEXIS, INC. | Materials | $1.2M | 0.9% | 526K | -0.3% | |||
| 30 | $ZETA | Zeta Global Holdings Corp. | Technology | $1.1M | 0.8% | 56K | — | |||
| 31 | $TLSI | TriSalus Life Sciences, Inc. | Healthcare | $1.1M | 0.8% | 235K | +2% | |||
| 32 | $TELA | TELA Bio, Inc. | Healthcare | $1.0M | 0.8% | 1.38M | -3% | |||
| 33 | $BDSX | BIODESIX INC | Healthcare | $1.0M | 0.8% | 45K | -0.4% | |||
| 34 | $SPAI | Safe Pro Group Inc. | Healthcare | $998K | 0.8% | 231K | -0.3% | |||
| 35 | $MRK | Merck & Co., Inc. | Healthcare | $964K | 0.7% | 7,500 | -3% | |||
| 36 | $GILD | GILEAD SCIENCES, INC. | Healthcare | $912K | 0.7% | 7,216 | — | |||
| 37 | $VTRS | Viatris Inc | Healthcare | $855K | 0.6% | 54K | -2% | |||
| 38 | $PFE | PFIZER INC | Healthcare | $813K | 0.6% | 34K | -6% | |||
| 39 | $BKSY | BlackSky Technology Inc. | Technology | $803K | 0.6% | 29K | — | |||
| 40 | $AAPL | Apple Inc. | Technology | $767K | 0.6% | 2,650 | — | |||
| 41 | $PROF | Profound Medical Corp. | Healthcare | $760K | 0.6% | 114K | — | |||
| 42 | $USB | US BANCORP \DE\ | Financials | $746K | 0.6% | 12K | -2% | |||
| 43 | $NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | Healthcare | $744K | 0.6% | 245K | -83% | |||
| 44 | $VIDA | VIDA Global Inc. | Technology | $700K | 0.5% | 250K | New | |||
| 45 | $TGT | TARGET CORP | Consumer Staples | $620K | 0.5% | 4,750 | -3% | |||
| 46 | $OWLT | Owlet, Inc. | Technology | $611K | 0.5% | 106K | +0.4% | |||
| 47 | $ELWT | Elauwit Connection, Inc. | Communication Services | $598K | 0.5% | 56K | — | |||
| 48 | $MDXH | MDxHealth SA | Healthcare | $580K | 0.4% | 1.41M | -4% | |||
| 49 | $STX | Seagate Technology Holdings plc | Technology | $507K | 0.4% | 525 | -5% | |||
| 50 | $ATRC | AtriCure, Inc. | Healthcare | $490K | 0.4% | 18K | -33% | |||
| 51 | $COP | CONOCOPHILLIPS | Energy | $483K | 0.4% | 4,650 | -4% | |||
| 52 | $NXPI | NXP Semiconductors N.V. | Technology | $478K | 0.4% | 1,700 | -6% | |||
| 53 | $LFVN | Lifevantage Corp | Healthcare | $471K | 0.3% | 75K | — | |||
| 54 | $CELC | Celcuity Inc. | Healthcare | $471K | 0.3% | 4,500 | -17% | |||
| 55 | $GIS | GENERAL MILLS INC | Consumer Staples | $434K | 0.3% | 8,375 | -6% | |||
| 56 | $SKYT | SkyWater Technology, LLC | Technology | $414K | 0.3% | 12K | -55% | |||
| 57 | $BMY | BRISTOL MYERS SQUIBB CO | Healthcare | $414K | 0.3% | 7,180 | -3% | |||
| 58 | $DCI | DONALDSON Co INC | Industrials | $413K | 0.3% | 4,600 | — | |||
| 59 | $QTI | QT IMAGING HOLDINGS, INC. | Healthcare | $407K | 0.3% | 100K | New | |||
| 60 | $VZ | VERIZON COMMUNICATIONS INC | Communication Services | $386K | 0.3% | 9,108 | — | |||
| 61 | $CSTL | CASTLE BIOSCIENCES INC | Healthcare | $385K | 0.3% | 16K | +5% | |||
| 62 | $ELUT | ELUTIA INC. | Healthcare | $380K | 0.3% | 694K | -8% | |||
| 63 | $FAST | FASTENAL CO | Industrials | $348K | 0.3% | 7,250 | — | |||
| 64 | $T | AT&T INC. | Communication Services | $331K | 0.3% | 16K | — | |||
| 65 | $BP | BP PLC | Energy | $320K | 0.2% | 8,650 | -6% | |||
| 66 | $JNJ | JOHNSON & JOHNSON | Healthcare | $305K | 0.2% | 1,200 | — | |||
| 67 | $BLNE | Beeline Holdings, Inc. | Financials | $290K | 0.2% | 238K | -3% | |||
| 68 | $MRNA | Moderna, Inc. | Healthcare | $280K | 0.2% | 4,000 | — | |||
| 69 | $XGN | EXAGEN INC. | Healthcare | $264K | 0.2% | 57K | -21% | |||
| 70 | $APYX | Apyx Medical Corp | Healthcare | $189K | 0.1% | 42K | — | |||
| 71 | $AIRG | AIRGAIN INC | Technology | $139K | 0.1% | 22K | — | |||
| 72 | $PBYI | PUMA BIOTECHNOLOGY, INC. | Healthcare | $109K | 0.1% | 13K | +7% | |||
| 73 | $OPRX | OptimizeRx Corp | Industrials | $85K | 0.1% | 15K | -7% | |||
| 74 | $IRIX | IRIDEX CORP | Healthcare | $81K | 0.1% | 71K | +28% | |||
| 75 | $CATX | Perspective Therapeutics, Inc. | Healthcare | $62K | 0.1% | 18K | New | |||
| 76 | $SOPH | SOPHiA GENETICS SA | Technology | $61K | 0.1% | 11K | — | |||
| 77 | $LUNG | Pulmonx Corp | Healthcare | $51K | 0.0% | 40K | -4% | |||
| 78 | $DYAI | DYADIC INTERNATIONAL INC | Healthcare | $43K | 0.0% | 48K | — | |||
| 79 | $ARAY | ACCURAY INC | Healthcare | $5K | 0.0% | 20K | -62% |
What changed in Q2 2026
Against the previous quarter's 13F: 4 new, 8 added to, 47 trimmed, 11 sold out. Share-count changes; largest moves by dollar size first.
New positions (4)
Added to (8)
$CXDOCrexendo, Inc.+9%
now $1.6M · held 3+ qtrs
$PERIPerion Network Ltd.+5%
now $1.6M · held 3+ qtrs, 2 adds in a row
$ATECAlphatec Holdings, Inc.+2%
now $1.5M · held 3+ qtrs
$TLSITriSalus Life Sciences, Inc.+2%
now $1.1M · held 2 qtrs, 2 adds in a row
$IRIXIRIDEX CORP+28%
now $81K · held 3+ qtrs, 2 adds in a row
$CSTLCASTLE BIOSCIENCES INC+5%
now $385K · held 3+ qtrs
+2 more in the Excel export
Trimmed (47)
$NMTCNEUROONE MEDICAL TECHNOLOGIES Corp-83%
now $744K · held 3+ qtrs
now $11.0M · held 3+ qtrs
now $5.1M · held 3+ qtrs
now $6.8M · held 3+ qtrs, 2 trims in a row
now $8.1M · held 3+ qtrs, 2 trims in a row
now $3.5M · held 3+ qtrs
+41 more in the Excel export
Holdings by quarter
Every 13F PERKINS CAPITAL MANAGEMENT INC has filed, 41 earlier quarters. Pick one to see what it held then.
Is it too late to follow PERKINS CAPITAL MANAGEMENT?
Q2 2026 13F filed with the SEC on Jul 24, 2026. Prices are closing prices as of Oct 26, 2026.
Average quality of PERKINS CAPITAL MANAGEMENT's top 20 holdings: 56/100 (our AI quality score, weighted by position size; 19 of the 20 are scored)
Top 10 since filing
+3.0%
Value-weighted move of the 10 largest stock positions
Turnover
2%
Last quarter
Top 10 weight
52%
Share of the stock portfolio in its 10 largest positions
Held 4+ quarters
0%
Share of portfolio value in positions held a year or more
Highest-quality names it owns(among its 100 largest positions)
The 8 highest-scoring companies in this portfolio are a Pro feature.
How these are measured
- Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
- Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
- Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q4 2025 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
- Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
- Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.
Portfolio Overview
PERKINS CAPITAL MANAGEMENT INC disclosed 79 positions worth $133.0M in its Form 13F-HR for Q2 2026, led by $NTRA (Natera, Inc.) at 8.3% of the equity portfolio, followed by $LLY and $AMD. During the quarter the fund opened 4 new positions and exited 11 — including a new stake in $CREX and a full exit from $INGN. The portfolio is most concentrated in Healthcare (56.1% of disclosed assets). All figures are sourced directly from PERKINS CAPITAL MANAGEMENT INC’s Form 13F-HR filing with the SEC under CIK 884300.
Funds like this
managers whose biggest positions overlap PERKINS CAPITAL MANAGEMENT'sBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
AI-Powered Hedge Fund Analysis: PERKINS CAPITAL MANAGEMENT INC
13F Pro is an AI hedge fund tracker and stock research platform. For PERKINS CAPITAL MANAGEMENT INC (SEC CIK: 884300), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in PERKINS CAPITAL MANAGEMENT INC's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.